Refine
Year of publication
Document Type
- Article (83)
- Preprint (8)
- Conference Proceeding (3)
- Diploma Thesis (1)
- Working Paper (1)
Has Fulltext
- yes (96)
Is part of the Bibliography
- no (96)
Keywords
- SARS-CoV-2 (3)
- Accelerators & Beams (2)
- Atomic, Molecular & Optical (2)
- COVID-19 (2)
- NMR spectroscopy (2)
- Outcome (2)
- RNA (2)
- Stroke (2)
- hypoxia (2)
- 3years (1)
- ARDS (1)
- ASCT (1)
- Accelerators & storage rings (1)
- Anti-kaon–nucleon physics (1)
- Aortic valve (1)
- Aortic valve replacement (1)
- Atomic & molecular beams (1)
- Attention-Deficit/Hyperactivity Disorder (ADHD) (1)
- Autism spectrum disorder (1)
- B.1.1.7 (1)
- BI1361849 (1)
- Baryonic resonances (1)
- Beam loss (1)
- Blood flow restriction (1)
- Brain asymmetry (1)
- CHIP (1)
- COVID (1)
- CV9202 (1)
- CVID (1)
- Cardiac surgery (1)
- Cerebrovascular (1)
- Charge-transfer collisions (1)
- Circular accelerators (1)
- Circulating miRNA (1)
- Clinical Trials and Observations (1)
- Clinical competence (1)
- Clinical frailty scale (1)
- Clinical trial (1)
- Contingent Negative Variation, CNV (1)
- Continuous Performance Test, CPT (1)
- Coronary heart disease (1)
- Couch tracking (1)
- Covid19-nmr (1)
- Critical care (1)
- Crystal structure (1)
- Cue-P3 (1)
- DME (1)
- Devic disease (1)
- Devic syndrome (1)
- EEG (1)
- Echovirus-30 (1)
- Ejection fraction (1)
- Electron-pion identification (1)
- Electronic transitions (1)
- Endurance training (1)
- European Society for Immunodeficiencies (ESID) (1)
- Event related potentials (1)
- Experimental models of disease (1)
- FFPE (1)
- Fast-track (1)
- Fibre/foam sandwich radiator (1)
- Flexible Endoscopic Evaluation of Swallowing (1)
- Frailty (1)
- Freezeout (1)
- GRAND-SLAM (1)
- German PID-NET registry (1)
- Gimbaled tracking (1)
- HAI‐1 (1)
- HGF (1)
- HIBCPP cells (1)
- Heavy-ion reactions (1)
- Hemispheric specialization (1)
- Heterogeneity (1)
- High-pressure (1)
- Hyperons (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- ILUVIEN (1)
- IgG substitution therapy (1)
- Immunomonitoring (1)
- Intensive care outcome (1)
- Ionisation energy loss (1)
- Kaonic nuclei (1)
- Language delay (1)
- Low & intermediate-energy accelerators (1)
- Low energy QCD (1)
- MLC tracking (1)
- Molecular biology (1)
- Multi-wire proportional drift chamber (1)
- Multianvil (1)
- Muscular diseases (1)
- Myeloid Neoplasia (1)
- N501Y (1)
- NADPH oxidase (1)
- NMO-IgG (1)
- NMR (1)
- Nervous system diseases (1)
- Neural network (1)
- Neurofeedback (1)
- Neuromyelitis optica (1)
- Non-small cell lung cancer (1)
- Normative modeling (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear astrophysics (1)
- Nuclear physics of explosive environments (1)
- Nuclear reactions (1)
- Nucleus (1)
- Organ motion (1)
- PID prevalence (1)
- Partial wave analysis (1)
- Photon counting (1)
- Polarization (1)
- Prognostic models (1)
- Proton (1)
- RNA stability (1)
- RNA, long noncoding (1)
- Radiation detectors (1)
- Radiative capture (1)
- Randomized Controlled Trial (1)
- Rare-earth borate (1)
- Reactive oxygen species (1)
- Readmission (1)
- Response control (1)
- Retro-IDEAL (1)
- Robotic tracking (1)
- SLAM-seq (1)
- SWATH (1)
- Slow Cortical Potentials, SCP (1)
- Stenosis (1)
- Steroid (1)
- Strangeness (1)
- Superoxide (1)
- Sustained attention (1)
- TR (1)
- Telomere length (1)
- Telomeres (1)
- Terbium (1)
- Thrombosis (1)
- Tracking (1)
- Transient (1)
- Transient ischemic attack (1)
- Transition radiation detector (1)
- Trigger (1)
- VIGALL (1)
- VIP1 (1)
- Vertigo (1)
- Water balance (1)
- White blood cells (1)
- Xenon-based gas mixture (1)
- accessory proteins (1)
- accident (1)
- adaptation (1)
- antibiotic therapy (1)
- aquaporin-4 (AQP4) antibody (1)
- arteriogenesis (1)
- autologous stem cell transplantation (1)
- available water capacity (1)
- biomarker (1)
- blood flow restriction (1)
- blood-cerebrospinal fluid barrier (1)
- bone healing (1)
- bone marrow mononuclear cells (1)
- bortezomib (1)
- breast tumor (1)
- cell-free protein synthesis (1)
- cerebrospinal fluid (1)
- chemotherapy (1)
- circulating miRNA (1)
- clinical features (1)
- clonal dominance (1)
- clonal hematopoiesis (1)
- dE/dx (1)
- de novo transcription (1)
- depression (1)
- drought-stress (1)
- drug resistance (1)
- enterovirus (1)
- epidemiology (1)
- epigenomics (1)
- evolution (1)
- fecal microbiota transfer (1)
- forest site classification (1)
- fragment screening (1)
- genetic diversity (1)
- glioblastoma (1)
- graft-vs-host disease (1)
- hematopoietic stem cells (1)
- hematopoietic stress (1)
- hepatitis C virus (HCV) (1)
- heteronuclear detection (1)
- human allogeneic hematopoietic cell transplantation (1)
- human decellularized dermis (1)
- human intestinal microbiota (1)
- hypertension, pulmonary (1)
- imaging (1)
- induced membrane (1)
- induction regimen (1)
- infections: pneumonia, TB, viral (1)
- injury (1)
- intrinsically disordered region (1)
- isotope labeling (1)
- kidney (1)
- large functional RNAs (1)
- lenalidomide (1)
- leukemia (1)
- lipid raft (1)
- lockdown (1)
- longitudinally extensive transverse myelitis (1)
- mRNA active cancer immunotherapy (1)
- macrophage (1)
- magnetic resonance imaging (1)
- miR (1)
- miR-142-5p (1)
- miR-143-3p (1)
- miR-197-3p (1)
- miR-342-3p (1)
- miR-424-5p (1)
- microdosing (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular dynamics (1)
- molecular surveillance (1)
- monocytes (1)
- multiple myeloma (1)
- natural selection (1)
- neovascularization, physiologic (1)
- nonstructural proteins (1)
- obesity (1)
- p47phox (1)
- pediatric intensive care (1)
- peripheral artery disease (1)
- ppK − (1)
- pressure cycling technology (1)
- primary immunodeficiency (PID) (1)
- proliferation (1)
- protease inhibitor (1)
- proteome (1)
- recurrent optic neuritis (1)
- registry for primary immunodeficiency (1)
- renal failure (1)
- replicative fitness (1)
- resistance mutation (1)
- serine protease (NS3-4A) (1)
- site classification system (1)
- sleepiness (1)
- somatic mutations (1)
- spike mutation (1)
- strength training (1)
- structural proteins (1)
- structure constraints (1)
- trauma (1)
- tumor (1)
- tumor microenvironment (1)
- tumor‐associated macrophages (1)
- viral infection (1)
- x-ray techniques (1)
Institute
- Medizin (53)
- Physik (26)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (5)
- ELEMENTS (5)
- Geowissenschaften (5)
- Biochemie und Chemie (4)
- Frankfurt Institute for Advanced Studies (FIAS) (4)
- Informatik (4)
- Sonderforschungsbereiche / Forschungskollegs (3)
- Biochemie, Chemie und Pharmazie (2)
Purpose: Scientific and clinical achievements in radiation, medical, and surgical oncology are changing the landscape of interdisciplinary oncology. The German Society for Radiation Oncology (DEGRO) working group of young clinicians and scientists (yDEGRO) and the DEGRO representation of associate and full professors (AKRO) are aware of the essential role of radiation oncology in multidisciplinary treatment approaches. Together, yDEGRO and AKRO endorsed developing a German radiotherapy & radiation oncology vision 2030 to address future challenges in patient care, research, and education. The vision 2030 aims to identify priorities and goals for the next decade in the field of radiation oncology. Methods: The vision development comprised three phases. During the first phase, areas of interest, objectives, and the process of vision development were defined jointly by the yDEGRO, AKRO, and the DEGRO board. In the second phase, a one-day strategy retreat was held to develop AKRO and yDEGRO representatives’ final vision from medicine, biology, and physics. The third phase was dedicated to vision interpretation and program development by yDEGRO representatives. Results: The strategy retreat’s development process resulted in conception of the final vision “Innovative radiation oncology Together – Precise, Personalized, Human.” The first term “Innovative radiation oncology” comprises the promotion of preclinical research and clinical trials and highlights the development of a national committee for strategic development in radiation oncology research. The term “together” underpins collaborations within radiation oncology departments as well as with other partners in the clinical and scientific setting. “Precise” mainly covers technological precision in radiotherapy as well as targeted oncologic therapeutics. “Personalized” emphasizes biology-directed individualization of radiation treatment. Finally, “Human” underlines the patient-centered approach and points towards the need for individual longer-term career curricula for clinicians and researchers in the field. Conclusion: The vision 2030 balances the ambition of physical, technological, and biological innovation as well as a comprehensive, patient-centered, and collaborative approach towards radiotherapy & radiation oncology in Germany.
We have measured the capture cross section of the 155Gd and 157Gd isotopes between 0.025 eV and 1 keV. The capture events were recorded by an array of 4 C6D6 detectors, and the capture yield was deduced exploiting the total energy detection system in combination with the Pulse Height Weighting Techniques. Because of the large cross section around thermal neutron energy, 4 metallic samples of different thickness were used to prevent problems related to self-shielding. The samples were isotopically enriched, with a cross contamination of the other isotope of less than 1.14%. The capture yield was analyzed with an R-Matrix code to describe the cross section in terms of resonance parameters. Near thermal energies, the results are significantly different from evaluations and from previous time-of-flight experiments. The data from the present measurement at n_TOF are publicly available in the experimental nuclear reaction database EXFOR.
New neutron cross section measurements of minor actinides have been performed recently in order to reduce the uncertainties in the evaluated data, which is important for the design of advanced nuclear reactors and, in particular, for determining their performance in the transmutation of nuclear waste. We have measured the 241Am(n,γ) cross section at the n_TOF facility between 0.2 eV and 10 keV with a BaF2 Total Absorption Calorimeter, and the analysis of the measurement has been recently concluded. Our results are in reasonable agreement below 20 eV with the ones published by C. Lampoudis et al. in 2013, who reported a 22% larger capture cross section up to 110 eV compared to experimental and evaluated data published before. Our results also indicate that the 241Am(n,γ) cross section is underestimated in the present evaluated libraries between 20 eV and 2 keV by 25%, on average, and up to 35% for certain evaluations and energy ranges.
The accuracy on neutron capture cross section of fissile isotopes must be improved for the design of future nuclear systems such as Gen-IV reactors and Accelerator Driven Systems. The High Priority Request List of the Nuclear Energy Agency, which lists the most important nuclear data requirements, includes also the neutron capture cross sections of fissile isotopes such as 233,235U and 239,241Pu. A specific experimental setup has been used at the CERN n_TOF facility for the measurement of the neutron capture cross section of 235U by a set of micromegas fission detectors placed inside a segmented BaF2 Total Absorption Calorimeter.
We report the first measurement of low-energy proton-capture cross sections of 124Xe in a heavy-ion storage ring. 124Xe54+ ions of five different beam energies between 5.5 and 8 AMeV were stored to collide with a windowless hydrogen target. The 125Cs reaction products were directly detected. The interaction energies are located on the high energy tail of the Gamow window for hot, explosive scenarios such as supernovae and x-ray binaries. The results serve as an important test of predicted astrophysical reaction rates in this mass range. Good agreement in the prediction of the astrophysically important proton width at low energy is found, with only a 30% difference between measurement and theory. Larger deviations are found above the neutron emission threshold, where also neutron and γ widths significantly impact the cross sections. The newly established experimental method is a very powerful tool to investigate nuclear reactions on rare ion beams at low center-of-mass energies.
MicroRNAs (miRNAs) are critical post-transcriptional regulators in many biological processes. They act by guiding RNA-induced silencing complexes to miRNA response elements (MREs) in target mRNAs, inducing translational inhibition and/or mRNA degradation. Functional MREs are expected to predominantly occur in the 3' untranslated region and involve perfect base-pairing of the miRNA seed. Here, we generate a high-resolution map of miR-181a/b-1 (miR-181) MREs to define the targeting rules of miR-181 in developing murine T-cells. By combining a multi-omics approach with computational high-resolution analyses, we uncover novel miR-181 targets and demonstrate that miR-181 acts predominantly through RNA destabilization. Importantly, we discover an alternative seed match and identify a distinct set of targets with repeat elements in the coding sequence which are targeted by miR-181 and mediate translational inhibition. In conclusion, deep profiling of MREs in primary cells is critical to expand physiologically relevant targetomes and establish context-dependent miRNA targeting rules.
The radiative electron capture (REC) into the K shell of bare Xe ions colliding with a hydrogen gas target has been investigated. In this study, the degree of linear polarization of the K-REC radiation was measured and compared with rigorous relativistic calculations as well as with the previous results recorded for U92+. Owing to the improved detector technology, a significant gain in precision of the present polarization measurement is achieved compared to the previously published results. The obtained data confirms that for medium-Z ions such as Xe, the REC process is a source of highly polarized x rays which can easily be tuned with respect to the degree of linear polarization and the photon energy. We argue, in particular, that for relatively low energies the photons emitted under large angles are almost fully linear polarized.
The 124Xe(p,γ) reaction has been measured for the first time at energies around the Gamow window by using stored ions at the ESR facility. The desired beam energies below 10 MeV/u introduce new experimental challenges like windowless ions detection under UHV conditions, extremely short beam lifetimes and efficient beam deceleration and cooling, all of which have been successfully met.
Background: To perform a comprehensive study on the relationship between vitamin D metabolism and the response to interferon-α-based therapy of chronic hepatitis C.
Methodology/Principal Findings: Associations between a functionally relevant polymorphism in the gene encoding the vitamin D 1α-hydroxylase (CYP27B1-1260 rs10877012) and the response to treatment with pegylated interferon-α (PEG-IFN-α) and ribavirin were determined in 701 patients with chronic hepatitis C. In addition, associations between serum concentrations of 25-hydroxyvitamin D3 (25[OH]D3) and treatment outcome were analysed. CYP27B1-1260 rs10877012 was found to be an independent predictor of sustained virologic response (SVR) in patients with poor-response IL28B genotypes (15% difference in SVR for rs10877012 genotype AA vs. CC, p = 0.02, OR = 1.52, 95% CI = 1.061–2.188), but not in patients with favourable IL28B genotype. Patients with chronic hepatitis C showed a high prevalence of vitamin D insufficiency (25[OH]D3<20 ng/mL) during all seasons, but 25(OH)D3 serum levels were not associated with treatment outcome.
Conclusions/Significance: Our study suggests a role of bioactive vitamin D (1,25[OH]2D3, calcitriol) in the response to treatment of chronic hepatitis C. However, serum concentration of the calcitriol precursor 25(OH)D3 is not a suitable predictor of treatment outcome.
Background: Vitamin D insufficiency has been associated with the occurrence of various types of cancer, but causal relationships remain elusive. We therefore aimed to determine the relationship between genetic determinants of vitamin D serum levels and the risk of developing hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).
Methodology/Principal Findings: Associations between CYP2R1, GC, and DHCR7 genotypes that are determinants of reduced 25-hydroxyvitamin D (25[OH]D3) serum levels and the risk of HCV-related HCC development were investigated for 1279 chronic hepatitis C patients with HCC and 4325 without HCC, respectively. The well-known associations between CYP2R1 (rs1993116, rs10741657), GC (rs2282679), and DHCR7 (rs7944926, rs12785878) genotypes and 25(OH)D3 serum levels were also apparent in patients with chronic hepatitis C. The same genotypes of these single nucleotide polymorphisms (SNPs) that are associated with reduced 25(OH)D3 serum levels were found to be associated with HCV-related HCC (P = 0.07 [OR = 1.13, 95% CI = 0.99–1.28] for CYP2R1, P = 0.007 [OR = 1.56, 95% CI = 1.12–2.15] for GC, P = 0.003 [OR = 1.42, 95% CI = 1.13–1.78] for DHCR7; ORs for risk genotypes). In contrast, no association between these genetic variations and liver fibrosis progression rate (P>0.2 for each SNP) or outcome of standard therapy with pegylated interferon-α and ribavirin (P>0.2 for each SNP) was observed, suggesting a specific influence of the genetic determinants of 25(OH)D3 serum levels on hepatocarcinogenesis.
Conclusions/Significance: Our data suggest a relatively weak but functionally relevant role for vitamin D in the prevention of HCV-related hepatocarcinogenesis.
Background: IL28B gene polymorphism is the best baseline predictor of response to interferon alfa-based antiviral therapies in chronic hepatitis C. Recently, a new IFN-L4 polymorphism was identified as first potential functional variant for induction of IL28B expression. Individualization of interferon alfa-based therapies based on a combination of IL28B/IFN-L4 polymorphisms may help to optimize virologic outcome and economic resources.
Methods: Optimization of treatment outcome prediction was assessed by combination of different IL28B and IFN-L4 polymorphisms in patients with chronic HCV genotype 1 (n = 385), 2/3 (n = 267), and 4 (n = 220) infection treated with pegylated interferon alfa (PEG-IFN) and ribavirin with (n = 79) or without telaprevir. Healthy people from Germany (n = 283) and Egypt (n = 96) served as controls.
Results: Frequencies of beneficial IL28B rs12979860 C/C genotypes were lower in HCV genotype 1/4 infected patients in comparison to controls (20–35% vs. 46–47%) this was also true for ss469415590 TT/TT (20–35% vs. 45–47%). Single interferon-lambda SNPs (rs12979860, rs8099917, ss469415590) correlated with sustained virologic response (SVR) in genotype 1, 3, and 4 infected patients while no association was observed for genotype 2. Interestingly, in genotype 3 infected patients, best SVR prediction was based on IFN-L4 genotype. Prediction of SVR with high accuracy (71–96%) was possible in genotype 1, 2, 3 and 4 infected patients who received PEG-IFN/ribavirin combination therapy by selection of beneficial IL28B rs12979860 C/C and/or ss469415590 TT/TT genotypes (p<0.001). For triple therapy with first generation protease inhibitors (PIs) (boceprevir, telaprevir) prediction of high SVR (90%) rates was based on the presence of at least one beneficial genotype of the 3 IFN-lambda SNPs.
Conclusion: IFN-L4 seems to be the best single predictor of SVR in genotype 3 infected patients. For optimized prediction of SVR by treatment with dual combination or first generation PI triple therapies, grouping of interferon-lambda haplotypes may be helpful with positive predictive values of 71–96%.
A wide variety of enzymatic pathways that produce specialized metabolites in bacteria, fungi and plants are known to be encoded in biosynthetic gene clusters. Information about these clusters, pathways and metabolites is currently dispersed throughout the literature, making it difficult to exploit. To facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters, we propose the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard.
Background: Different parameters have been determined for prediction of treatment outcome in hepatitis c virus genotype 1 infected patients undergoing pegylated interferon, ribavirin combination therapy. Results on the importance of vitamin D levels are conflicting. In the present study, a comprehensive analysis of vitamin D levels before and during therapy together with single nucleotide polymorphisms involved in vitamin D metabolism in the context of other known treatment predictors has been performed.
Methods: In a well characterized prospective cohort of 398 genotype 1 infected patients treated with pegylated interferon-α and ribavirin for 24–72 weeks (INDIV-2 study) 25-OH-vitamin D levels and different single nucleotide polymorphisms were analyzed together with known biochemical parameters for a correlation with virologic treatment outcome.
Results: Fluctuations of more than 5 (10) ng/ml in 25-OH-vitamin D-levels have been observed in 66 (39) % of patients during the course of antiviral therapy and neither pretreatment nor under treatment 25-OH-vitamin D-levels were associated with treatment outcome. The DHCR7-TT-polymorphism within the 7-dehydrocholesterol-reductase showed a significant association (P = 0.031) to sustained viral response in univariate analysis. Among numerous further parameters analyzed we found that age (OR = 1.028, CI = 1.002–1.056, P = 0.035), cholesterol (OR = 0.983, CI = 0.975–0.991, P<0.001), ferritin (OR = 1.002, CI = 1.000–1.004, P = 0.033), gGT (OR = 1.467, CI = 1.073–2.006, P = 0.016) and IL28B-genotype (OR = 2.442, CI = 1.271–4.695, P = 0.007) constituted the strongest predictors of treatment response.
Conclusions: While 25-OH-vitamin D-levels levels show considerable variations during the long-lasting course of antiviral therapy they do not show any significant association to treatment outcome in genotype 1 infected patients.
Herein, the high-pressure/high-temperature synthesis (11 GPa, 650 °C) of Tb3B10O17(OH)5 in a modified Walker-type multianvil device is presented. The structure of this rare-earth borate was determined by single-crystal X-ray diffraction methods and was found to crystallize orthorhombically in the space group Pmn21 (no. 31) with the unit cell parameters a = 16.2527(4), b = 4.4373(1), and c = 8.8174(2) Å. The new compound was further characterized using infrared spectroscopy, energy-dispersive X-ray spectroscopy, second harmonic generation (SHG) measurements, and temperature-dependent X-ray powder diffraction. Tb3B10O17(OH)5 decomposes to β-Tb(BO2)3 at temperatures higher than 460 °C. With increasing temperatures, the formation of μ-TbBO3 was observed, which transforms to π-TbBO3 upon cooling.
Children’s and adolescents’ lives drastically changed during COVID lockdowns worldwide. To compare accident- and injury-related admissions to pediatric intensive care units (PICU) during the first German COVID lockdown with previous years, we conducted a retrospective multicenter study among 37 PICUs (21.5% of German PICU capacities). A total of 1444 admissions after accidents or injuries during the first lockdown period and matched periods of 2017–2019 were reported and standardized morbidity ratios (SMR) were calculated. Total PICU admissions due to accidents/injuries declined from an average of 366 to 346 (SMR 0.95 (CI 0.85–1.05)). Admissions with trauma increased from 196 to 212 (1.07 (0.93–1.23). Traffic accidents and school/kindergarten accidents decreased (0.77 (0.57–1.02 and 0.26 (0.05–0.75)), whereas household and leisure accidents increased (1.33 (1.06–1.66) and 1.34 (1.06–1.67)). Less neurosurgeries and more visceral surgeries were performed (0.69 (0.38–1.16) and 2.09 (1.19–3.39)). Non-accidental non-suicidal injuries declined (0.73 (0.42–1.17)). Suicide attempts increased in adolescent boys (1.38 (0.51–3.02)), but decreased in adolescent girls (0.56 (0.32–0.79)). In summary, changed trauma mechanisms entailed different surgeries compared to previous years. We found no evidence for an increase in child abuse cases requiring intensive care. The increase in suicide attempts among boys demands investigation.
The electron-capture process was studied for Xe54+ colliding with H2 molecules at the internal gas target of the Experimental Storage Ring (ESR) at GSI, Darmstadt. Cross-section values for electron capture into excited projectile states were deduced from the observed emission cross section of Lyman radiation, being emitted by the hydrogenlike ions subsequent to the capture of a target electron. The ion beam energy range was varied between 5.5 and 30.9 MeV/u by applying the deceleration mode of the ESR. Thus, electron-capture data were recorded at the intermediate and, in particular, the low-collision-energy regime, well below the beam energy necessary to produce bare xenon ions. The obtained data are found to be in reasonable qualitative agreement with theoretical approaches, while a commonly applied empirical formula significantly overestimates the experimental findings.